Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 24 September 1982:
Vol. 217. no. 4566, pp. 1250 - 1252
DOI: 10.1126/science.6896768

Articles

Science, Vol 217, Issue 4566, 1250-1252
Copyright © 1982 by American Association for the Advancement of Science


articles

Chemoprevention of neonatal jaundice: potency of tin-protoporphyrin in an animal model

GS Drummond and A Kappas

The substantial increases of hepatic, splenic, and renal heme oxygenase levels that occur shortly after birth in neonatal rats were prevented by a single administration of tin-protoporphyrin (10 micromoles per kilogram of body weight). With this treatment serum bilirubin levels declined within 24 hours to near-normal adult levels and remained low throughout the postnatal period. Zinc-protoporphyrin at doses up to 50-fold greater than the effective dose of tin-protoporphyrin did not prevent the immediate increases in tissue heme oxygenase activities and in serum bilirubin levels that occur postnatally. Studies in vitro with microsomal heme oxygenase in human spleen indicate that tin-protoporphyrin is a potent competitive inhibitor of the oxidation of heme to bile pigment in this tissue.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Haeme oxygenase promotes progenitor cell mobilization, neovascularization, and functional recovery after critical hindlimb ischaemia in mice.
J. Tongers, J.-M. Knapp, M. Korf, T. Kempf, A. Limbourg, F. P. Limbourg, Z. Li, D. Fraccarollo, J. Bauersachs, X. Han, et al. (2008)
Cardiovasc Res 78, 294-300
   Abstract »    Full Text »    PDF »
Pharmacological and Clinical Aspects of Heme Oxygenase.
N. G. Abraham and A. Kappas (2008)
Pharmacol. Rev. 60, 79-127
   Abstract »    Full Text »    PDF »
Tin protoporphyrin induces intestinal chloride secretion by inducing light oxidation processes.
A. Uc, K. J. Reszka, G. R. Buettner, and J. B. Stokes (2007)
Am J Physiol Cell Physiol 292, C1906-C1914
   Abstract »    Full Text »    PDF »
Motexafin Gadolinium-Induced Cell Death Correlates with Heme oxygenase-1 Expression and Inhibition of P450 Reductase-Dependent Activities.
J. P. Evans, F. Xu, M. Sirisawad, R. Miller, L. Naumovski, and P. R. O. de Montellano (2007)
Mol. Pharmacol. 71, 193-200
   Abstract »    Full Text »    PDF »
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications.
S. W. Ryter, J. Alam, and A. M. K. Choi (2006)
Physiol Rev 86, 583-650
   Abstract »    Full Text »    PDF »
Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats.
D Sacerdoti, B Escalante, N. Abraham, J. McGiff, R. Levere, and M. Schwartzman (1989)
Science 243, 388-390
   Abstract »    PDF »
Suppression of Carbon Monoxide Excretion Rate by Tin Protoporphyrin.
A. M. Posselt, L. K. Kwong, H. J. Vreman, and D. K. Stevenson (1986)
Arch Pediatr Adolesc Med 140, 147-150
   Abstract »    PDF »
Implications for Risk Assessment of Host Factors Causing Large Pharmacokinetic Variations.
E. S. Vesell (1985)
Toxicology and Industrial Health 1, 135-152
   Abstract »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)